Skip to main navigation Skip to search Skip to main content

WATCHMAN FLX versus NOAC for EMbolic ProtectION in the Management of Patients with Non-Valvular Atrial Fibrillation

Project: Research

Project Details

StatusActive
Effective start/end date03/16/2110/1/27

Funding

  • Boston Scientific Corporation: $39,244.99